Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions

Neurochemistry International

Volumn 89, Issue , 2015, Pages 209-226

  Sandhir, Rajat ^a   Yadav, Aarti ^a   Sunkaria, Aditya ^a   Singhal, Nitin ^b  

^a PANJAB UNIVERSITY   (India)

^b NATIONAL AGRI FOOD BIOTECHNOLOGY INSTITUTE   (India)

Author keywords

Antioxidants; Blood brain barrier; Brain; Nanoantioxidants; Nanoparticles; Neurodegeneration

Indexed keywords

ANTIOXIDANT; FREE RADICAL; NANOANTIOXIDANT; NANOPARTICLE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CHEMICAL INTERACTION; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; EVOLUTION; HUMAN; MOLECULE; NANOENCAPSULATION; NANOMEDICINE; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SYNTHESIS; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; METABOLISM; NEURODEGENERATIVE DISEASES; PHYSIOLOGY; TRENDS;

ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84942292987     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.08.011     Document Type: Review

References (302)

1. N.J. Abbott Astrocyte-endothelial interactions and blood-brain barrier permeability J. Anat. 200 2002 629 638
2. N.J. Abbott Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology Neurochem. Int. 45 2004 545 552
3. P. Ader, A. Wessmann, and S. Wolffram Bioavailability and metabolism of the flavonol quercetin in the pig Free Radic. Biol. Med. 28 2000 1056 1067
4. H. Amiri, K. Saeidi, P. Borhani, A. Manafirad, M. Ghavami, and V. Zerbi Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents ACS Chem. Neurosci. 4 2013 1417 1429
5. A. Amri, J.C. Chaumeil, S. Sfar, and C. Charrueau Administration of resveratrol: what formulation solutions to bioavailability limitations? J. Control Release 158 2012 182 193
6. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
7. A. Anandhan, K. Tamilselvam, D. Vijayraja, N. Ashokkumar, S. Rajasankar, and T. Manivasagam Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice Ann. Neurosci. 17 2010 113 119
8. A. Arya, N.K. Sethy, M. Das, S.K. Singh, A. Das, S.K. Ujjain, R.K. Sharma, M. Sharma, and K. Bhargava Cerium oxide nanoparticles prevent apoptosis in primary cortical culture by stabilizing mitochondrial membrane potential Free Radic. Res. 48 2014 784 793
9. W.A. Banks, and A.J. Kastin Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier Neurosci. Biobehav Rev. 13 1989 47 53
10. G. Bao, S. Mitragotri, and S. Tong Multifunctional nanoparticles for drug delivery and molecular imaging Annu. Rev. Biomed. Eng. 15 2013 253 282
11. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 2007 748 758
12. A.S. Basso, D. Frenkel, F.J. Quintana, F.A. Costa-Pinto, S. Petrovic-Stojkovic, L. Puckett, A. Monsonego, A. Bar-Shir, Y. Engel, M. Gozin, and H.L. Weiner Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis J. Clin. Invest. 118 2008 1532 1543
13. S. Bastianetto, and R. Quirion Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule Exp. Neurol. 225 2010 237 239
14. E.V. Batrakova, S. Li, A.D. Reynolds, R.L. Mosley, T.K. Bronich, A.V. Kabanov, and H.E. Gendelman A macrophage-nanozyme delivery system for Parkinson's disease Bioconjug. Chem. 18 2007 1498 1506
15. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, P.J. Pistell, S. Poosala, K.G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K.W. Fishbein, R.G. Spencer, E.G. Lakatta, D. Le Couteur, R.J. Shaw, P. Navas, P. Puigserver, D.K. Ingram, R. de Cabo, and D.A. Sinclair Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
16. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discov. 5 2006 493 506
17. R.J. Bernardi, A.R. Lowery, P.A. Thompson, S.M. Blaney, and J.L. West Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines J. Neurooncol. 86 2008 165 172
18. D.J. Bharali, and S.A. Mousa Relevance of nanotechnology in modulating oxidative stress: an overview Methods Mol. Biol. 1028 2013 289 292
19. J.P. Blass Cerebrometabolic abnormalities in Alzheimer's disease Neurol. Res. 25 2003 556 566
20. S.V. Boddapati, P. Tongcharoensirikul, R.N. Hanson, G.G. D'Souza, V.P. Torchilin, and V. Weissig Mitochondriotropic liposomes J. Liposome Res. 15 2005 49 58
21. M.L. Bondi, E.F. Craparo, G. Giammona, and F. Drago Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution Nanomed. (Lond.) 5 2010 25 32
22. S. Bosi, T. Da Ros, G. Spalluto, and M. Prato Fullerene derivatives: an attractive tool for biological applications Eur. J. Med. Chem. 38 2003 913 923
23. B.J. Boyd, A. Galle, M. Daglas, J.V. Rosenfeld, and R. Medcalf Traumatic brain injury opens blood-brain barrier to stealth liposomes via an enhanced permeability and retention (EPR)-like effect J. Drug Target 2015 1 7
24. A.M. Brynskikh, Y. Zhao, R.L. Mosley, S. Li, M.D. Boska, N.L. Klyachko, A.V. Kabanov, H.E. Gendelman, and E.V. Batrakova Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease Nanomed. (Lond.) 5 2010 379 396
25. V. Calabrese, T.E. Bates, C. Mancuso, C. Cornelius, B. Ventimiglia, M.T. Cambria, L. Di Renzo, A. De Lorenzo, and A.T. Dinkova-Kostova Curcumin and the cellular stress response in free radical-related diseases Mol. Nutr. Food Res. 52 2008 1062 1073
26. R.T. Carroll, D. Bhatia, W. Geldenhuys, R. Bhatia, N. Miladore, A. Bishayee, and V. Sutariya Brain-targeted delivery of tempol-loaded nanoparticles for neurological disorders J. Drug Target 18 2010 665 674
27. M.S. Cartiera, E.C. Ferreira, C. Caputo, M.E. Egan, M.J. Caplan, and W.M. Saltzman Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin Mol. Pharm. 7 2010 86 93
28. T.M. Chang Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 2010 418 430
29. G.J. Charrois, and T.M. Allen Multiple injections of pegylated liposomal doxorubicin: pharmacokinetics and therapeutic activity J. Pharmacol. Exp. Ther. 306 2003 1058 1067
30. S.R. Chavali, T. Utsunomiya, and R.A. Forse Increased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil Crit. Care Med. 29 2001 140 143
31. K.K. Cheng, P.S. Chan, S. Fan, S.M. Kwan, K.L. Yeung, Y.X. Wang, A.H. Chow, E.X. Wu, and L. Baum Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI) Biomaterials 44 2015 155 172
32. K.K. Cheng, C.F. Yeung, S.W. Ho, S.F. Chow, A.H. Chow, and L. Baum Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice AAPS J. 15 2013 324 336
33. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters, and A.I. Bush Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 30 2001 665 676
34. R. Chhillar, and D. Dhingra Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress Fundam. Clin. Pharmacol. 27 2013 409 418
35. L.S. Chia, J.E. Thompson, and M.A. Moscarello Changes in lipid phase behaviour in human myelin during maturation and aging. Involvement of lipid peroxidation FEBS Lett. 157 1983 155 158
36. G.B. Chiarotto, L. Drummond, G. Cavarretto, A.L. Bombeiro, and A.L. de Oliveira Neuroprotective effect of tempol (4 hydroxy-tempo) on neuronal death induced by sciatic nerve transection in neonatal rats Brain Res. Bull. 106 2014 1 8
37. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B. Itty Ipe, M.G. Bawendi, and J.V. Frangioni Renal clearance of quantum dots Nat. Biotechnol. 25 2007 1165 1170
38. A. Cimini, B. D'Angelo, S. Das, R. Gentile, E. Benedetti, V. Singh, A.M. Monaco, S. Santucci, and S. Seal Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Abeta aggregates modulate neuronal survival pathways Acta Biomater. 8 2012 2056 2067
39. G.M. Cole, B. Teter, and S.A. Frautschy Neuroprotective effects of curcumin Adv. Exp. Med. Biol. 595 2007 197 212
40. J. Colon, N. Hsieh, A. Ferguson, P. Kupelian, S. Seal, D.W. Jenkins, and C.H. Baker Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2 Nanomedicine 6 2010 698 705
41. P. Couvreur Nanotechnologies for designing new medicines Biol. Aujourdhui 206 2012 237 248
42. F.A. Cupaioli, F.A. Zucca, D. Boraschi, and L. Zecca Engineered nanoparticles. How brain friendly is this new guest? Prog. Neurobiol. 119-120 2014 20 38
43. G. da Rocha Lindner, D. Bonfanti Santos, D. Colle, E.L. Gasnhar Moreira, R. Daniel Prediger, M. Farina, N.M. Khalil, and R. Mara Mainardes Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism Nanomed. (Lond.) 10 2015 1127 1138
44. M. Daglia, A. Di Lorenzo, S.F. Nabavi, Z.S. Talas, and S.M. Nabavi Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat! Curr. Pharm. Biotechnol. 15 2014 362 372
45. L. Dal Bosco, G.E. Weber, G.M. Parfitt, A.P. Cordeiro, S.K. Sahoo, C. Fantini, M.C. Klosterhoff, L.A. Romano, C.A. Furtado, A.P. Santos, J.M. Monserrat, and D.M. Barros Biopersistence of PEGylated carbon nanotubes promotes a delayed antioxidant response after infusion into the rat Hippocampus PLoS One 10 2015 e0129156
46. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Preat PLGA-based nanoparticles: an overview of biomedical applications J. Control Release 161 2012 505 522
47. M. Das, S. Patil, N. Bhargava, J.F. Kang, L.M. Riedel, S. Seal, and J.J. Hickman Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons Biomaterials 28 2007 1918 1925
48. S. Das, A.K. Mandal, A. Ghosh, S. Panda, N. Das, and S. Sarkar Nanoparticulated quercetin in combating age related cerebral oxidative injury Curr. Aging Sci. 1 2008 169 174
49. E.S. Day, P.A. Thompson, L. Zhang, N.A. Lewinski, N. Ahmed, R.A. Drezek, S.M. Blaney, and J.L. West Nanoshell-mediated photothermal therapy improves survival in a murine glioma model J. Neurooncol. 104 2011 55 63
50. V.C. de Boer, A.A. Dihal, H. van der Woude, I.C. Arts, S. Wolffram, G.M. Alink, I.M. Rietjens, J. Keijer, and P.C. Hollman Tissue distribution of quercetin in rats and pigs J. Nutr. 135 2005 1718 1725
51. W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles:applications and hazards Int. J. Nanomed. 3 2008 133 149
52. J.M. de la Fuente, and C.C. Berry Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus Bioconjug. Chem. 16 2005 1176 1180
53. M.A. De Luca, F. Lai, F. Corrias, P. Caboni, Z. Bimpisidis, E. Maccioni, A.M. Fadda, and G. Di Chiara Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: preparation and in vivo evaluation Int. J. Pharm. 479 2015 129 137
54. D. Della-Morte, K.R. Dave, R.A. DeFazio, Y.C. Bao, A.P. Raval, and M.A. Perez-Pinzon Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway Neuroscience 159 2009 993 1002
55. D. Dhingra, R. Chhillar, and A. Gupta Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system Neurochem. Res. 37 2012 487 494
56. F. Dilnawaz, and S.K. Sahoo Therapeutic approaches of magnetic nanoparticles for the central nervous system Drug Discov. Today 2015 10.1016/j.drudis.2015.06.008 [Epub ahead of print]
57. P. Divakaran, and R.C. Wiggins Tocopherol in brain metabolism and disease: a review Metab. Brain Dis. 2 1987 1 16
58. P. Dohare, M.C. Hyzinski-Garcia, A. Vipani, N.H. Bowens, J.W. Nalwalk, P.J. Feustel, R.W. Keller Jr., D. Jourd'heuil, and A.A. Mongin The neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of stroke Free Radic. Biol. Med. 77 2014 168 182
59. D. Dorniani, A.U. Kura, S.H. Hussein-Al-Ali, M.Z. Bin Hussein, S. Fakurazi, A.H. Shaari, and Z. Ahmad In vitro sustained release study of gallic acid coated with magnetite-PEG and magnetite-PVA for drug delivery system Sci. World J. 2014 2014 416354
60. J.M. Dowding, W. Song, K. Bossy, A. Karakoti, A. Kumar, A. Kim, B. Bossy, S. Seal, M.H. Ellisman, G. Perkins, W.T. Self, and E. Bossy-Wetzel Cerium oxide nanoparticles protect against Abeta-induced mitochondrial fragmentation and neuronal cell death Cell Death Differ. 21 2014 1622 1632
61. L. Du, J. Li, C. Chen, and Y. Liu Nanocarrier: a potential tool for future antioxidant therapy Free Radic. Res. 48 2014 1061 1069
62. L.L. Dugan, J.K. Gabrielsen, S.P. Yu, T.S. Lin, and D.W. Choi Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons Neurobiol. Dis. 3 1996 129 135
63. L.L. Dugan, E.G. Lovett, K.L. Quick, J. Lotharius, T.T. Lin, and K.L. O'Malley Fullerene-based antioxidants and neurodegenerative disorders Park. Relat. Disord. 7 2001 243 246
64. L.L. Dugan, L. Tian, K.L. Quick, J.I. Hardt, M. Karimi, C. Brown, S. Loftin, H. Flores, S.M. Moerlein, J. Polich, S.D. Tabbal, J.W. Mink, and J.S. Perlmutter Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates Ann. Neurol. 76 2014 393 402
65. D.E. Ehrnhoefer, M. Duennwald, P. Markovic, J.L. Wacker, S. Engemann, M. Roark, J. Legleiter, J.L. Marsh, L.M. Thompson, S. Lindquist, P.J. Muchowski, and E.E. Wanker Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models Hum. Mol. Genet. 15 2006 2743 2751
66. A. Elder, R. Gelein, V. Silva, T. Feikert, L. Opanashuk, J. Carter, R. Potter, A. Maynard, Y. Ito, J. Finkelstein, and G. Oberdorster Translocation of inhaled ultrafine manganese oxide particles to the central nervous system Environ. Health Perspect. 114 2006 1172 1178
67. A.Y. Estevez, S. Pritchard, K. Harper, J.W. Aston, A. Lynch, J.J. Lucky, J.S. Ludington, P. Chatani, W.P. Mosenthal, J.C. Leiter, S. Andreescu, and J.S. Erlichman Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia Free Radic. Biol. Med. 51 2011 1155 1163
68. Y. Farbood, A. Sarkaki, S. Hashemi, M.T. Mansouri, and M. Dianat The effects of gallic acid on pain and memory following transient global ischemia/reperfusion in Wistar rats Avicenna J. Phytomed. 3 2013 329 340
69. F. Figueiro, A. Bernardi, R.L. Frozza, T. Terroso, A. Zanotto-Filho, E.H. Jandrey, J.C. Moreira, C.G. Salbego, M.I. Edelweiss, A.R. Pohlmann, S.S. Guterres, and A.M. Battastini Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth J. Biomed. Nanotechnol. 9 2013 516 526
70. R. Fischer, and O. Maier Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF Oxid. Med. Cell Longev. 2015 2015 610813
71. P. Flachenecker Epidemiology of neuroimmunological diseases J. Neurol. 253 Suppl. 5 2006 V2 V8
72. A. Flierl, C. Jackson, B. Cottrell, D. Murdock, P. Seibel, and D.C. Wallace Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid Mol. Ther. 7 2003 550 557
73. G. Flora, D. Gupta, and A. Tiwari Preventive efficacy of bulk and nanocurcumin against lead-induced oxidative stress in mice Biol. Trace Elem. Res. 152 2013 31 40
74. F. Fluri, D. Grunstein, E. Cam, U. Ungethuem, F. Hatz, J. Schafer, S. Samnick, I. Israel, C. Kleinschnitz, G. Orts-Gil, H. Moch, T. Zeis, N. Schaeren-Wiemers, and P. Seeberger Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats Exp. Neurol. 265 2015 142 151
75. C. Fornaguera, A. Dols-Perez, G. Caldero, M.J. Garcia-Celma, J. Camarasa, and C. Solans PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier J. Control Release 211 2015 134 143
76. H.W. Frijlink, E.J. Franssen, A.C. Eissens, R. Oosting, C.F. Lerk, and D.K. Meijer The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat Pharm. Res. 8 1991 380 384
77. R.L. Frozza, A. Bernardi, J.B. Hoppe, A.B. Meneghetti, A.M. Battastini, A.R. Pohlmann, S.S. Guterres, and C. Salbego Lipid-core nanocapsules improve the effects of resveratrol against Abeta-induced neuroinflammation J. Biomed. Nanotechnol. 9 2013 2086 2104
78. R.L. Frozza, A. Bernardi, J.B. Hoppe, A.B. Meneghetti, A. Matte, A.M. Battastini, A.R. Pohlmann, S.S. Guterres, and C. Salbego Neuroprotective effects of resveratrol against Abeta administration in rats are improved by lipid-core nanocapsules Mol. Neurobiol. 47 2013 1066 1080
79. P.J. Gaillard, C.C. Appeldoorn, R. Dorland, J. van Kregten, F. Manca, D.J. Vugts, B. Windhorst, G.A. van Dongen, H.E. de Vries, D. Maussang, and O. van Tellingen Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101) PLoS One 9 2014 e82331
80. N. Gao, H. Sun, K. Dong, J. Ren, and X. Qu Gold-nanoparticle-based multifunctional amyloid-beta inhibitor against Alzheimer's disease Chemistry 21 2015 829 835
81. X. Gao, W. Tao, W. Lu, Q. Zhang, Y. Zhang, X. Jiang, and S. Fu Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration Biomaterials 27 2006 3482 3490
82. M. Garcia-Alloza, L.A. Borrelli, A. Rozkalne, B.T. Hyman, and B.J. Bacskai Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model J. Neurochem. 102 2007 1095 1104
83. A. Gautam, K. Chaudhary, R. Kumar, A. Sharma, P. Kapoor, A. Tyagi, and G.P. Raghava In silico approaches for designing highly effective cell penetrating peptides J. Transl. Med. 11 2013 74
84. A. Ghanizadeh Gold nanoparticles and lipoic acid as a novel anti-inflammatory treatment for autism, a hypothesis J. Med. Hypo Ideas 6 2012 40 43
85. A. Ghosh, A.K. Mandal, S. Sarkar, S. Panda, and N. Das Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats Life Sci. 84 2009 75 80
86. A. Ghosh, S. Sarkar, A.K. Mandal, and N. Das Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats PLoS One 8 2013 e57735
87. J.L. Gilmore, X. Yi, L. Quan, and A.V. Kabanov Novel nanomaterials for clinical neuroscience J. Neuroimmune Pharmacol. 3 2008 83 94
88. D. Giust, D. Leon, I. Ballesteros-Yanez, T. Da Ros, J.L. Albasanz, and M. Martin Modulation of adenosine receptors by [60]fullerene hydrosoluble derivative in SK-N-MC cells ACS Chem. Neurosci. 2 2011 363 369
89. J. Glebska, L. Pulaski, K. Gwozdzinski, and J. Skolimowski Structure-activity relationship studies of protective function of nitroxides in Fenton system Biometals 14 2001 159 170
90. A. Goel, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin as "Curecumin": from kitchen to clinic Biochem. Pharmacol. 75 2008 787 809
91. V. Granados-Soto Pleiotropic effects of resveratrol Drug News Perspect. 16 2003 299 307
92. S. Guerrero, E. Araya, J.L. Fiedler, J.I. Arias, C. Adura, F. Albericio, E. Giralt, J.L. Arias, M.S. Fernandez, and M.J. Kogan Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide Nanomed. (Lond.) 5 2010 897 913
93. W. Guo, A. Li, Z. Jia, Y. Yuan, H. Dai, and H. Li Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma Eur. J. Pharmacol. 718 2013 41 47
94. H. Gupta, P. Paul, N. Kumar, S. Baxi, and D.P. Das One pot synthesis of water-dispersible dehydroascorbic acid coated Fe3O4 nanoparticles under atmospheric air: blood cell compatibility and enhanced magnetic resonance imaging J. Colloid Interface Sci. 430 2014 221 228
95. Y. Gupta, A. Jain, and S.K. Jain Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain J. Pharm. Pharmacol. 59 2007 935 940
96. Y. Hanasaki, S. Ogawa, and S. Fukui The correlation between active oxygens scavenging and antioxidative effects of flavonoids Free Radic. Biol. Med. 16 1994 845 850
97. M.J. Haney, P. Suresh, Y. Zhao, G.D. Kanmogne, I. Kadiu, M. Sokolsky-Papkov, N.L. Klyachko, R.L. Mosley, A.V. Kabanov, H.E. Gendelman, and E.V. Batrakova Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery Nanomedicine (Lond) 7 2012 815 833
98. T. Harmia, P. Speiser, and J. Kreuter A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles J. Microencapsul. 3 1986 3 12
99. B. Havsteen Flavonoids, a class of natural products of high pharmacological potency Biochem. Pharmacol. 32 1983 1141 1148
100. E.G. Heckert, A.S. Karakoti, S. Seal, and W.T. Self The role of cerium redox state in the SOD mimetic activity of nanoceria Biomaterials 29 2008 2705 2709
101. K.L. Heckman, W. DeCoteau, A. Estevez, K.J. Reed, W. Costanzo, D. Sanford, J.C. Leiter, J. Clauss, K. Knapp, C. Gomez, P. Mullen, E. Rathbun, K. Prime, J. Marini, J. Patchefsky, A.S. Patchefsky, R.K. Hailstone, and J.S. Erlichman Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain ACS Nano 7 2013 10582 10596
102. L.R. Hirsch, A.M. Gobin, A.R. Lowery, F. Tam, R.A. Drezek, N.J. Halas, and J.L. West Metal nanoshells Ann. Biomed. Eng. 34 2006 15 22
103. R.D. Hofheinz, S.U. Gnad-Vogt, U. Beyer, and A. Hochhaus Liposomal encapsulated anti-cancer drugs Anticancer Drugs 16 2005 691 707
104. E. Hood, E. Simone, P. Wattamwar, T. Dziubla, and V. Muzykantov Nanocarriers for vascular delivery of antioxidants Nanomed. (Lond.) 6 2011 1257 1272
105. A. Hosseini, A.M. Sharifi, M. Abdollahi, R. Najafi, M. Baeeri, S. Rayegan, J. Cheshmehnour, S. Hassani, Z. Bayrami, and M. Safa Cerium and yttrium oxide nanoparticles against lead-induced oxidative stress and apoptosis in rat hippocampus Biol. Trace Elem. Res. 164 2015 80 89
106. R.C. Hou, Y.S. Chen, C.H. Chen, Y.H. Chen, and K.C. Jeng Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells J. Biomed. Sci. 13 2006 89 99
107. B.J. Howard, S. Yatin, K. Hensley, K.L. Allen, J.P. Kelly, J. Carney, and D.A. Butterfield Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (tempol) J. Neurochem. 67 1996 2045 2050
108. C.L. Hsieh, Y.C. Lin, G.C. Yen, and H.Y. Chen Preventive effects of guava (Psidium guajava L.) leaves and its active compounds against α-dicarbonyl compounds-induced blood coagulation Food Chem. 103 2007 528 535
109. D.Z. Hsu, K.T. Chen, Y.H. Li, Y.C. Chuang, and M.Y. Liu Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress Shock 25 2006 528 532
110. H.L. Huang, C.C. Lin, K.C. Jeng, P.W. Yao, L.T. Chuang, S.L. Kuo, and C.W. Hou Fresh green tea and gallic acid ameliorate oxidative stress in kainic acid-induced status epilepticus J. Agric. Food Chem. 60 2012 2328 2336
111. A.F. Hubbs, R.R. Mercer, S.A. Benkovic, J. Harkema, K. Sriram, D. Schwegler-Berry, M.P. Goravanahally, T.R. Nurkiewicz, V. Castranova, and L.M. Sargent Nanotoxicology - a pathologist's perspective Toxicol. Pathol. 39 2011 301 324
112. E. Hutter, S. Boridy, S. Labrecque, M. Lalancette-Hebert, J. Kriz, F.M. Winnik, and D. Maysinger Microglial response to gold nanoparticles ACS Nano 4 2010 2595 2606
113. T.K. Indira, and P.K. Lakshmi Magnetic nanoparticles - a review Int. J. Pharm. Sci. Nanotech. 3 2010 1035 1042
114. A. Iqbal, I. Ahmad, M.H. Khalid, M.S. Nawaz, S.H. Gan, and M.A. Kamal Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 31 2013 256 284
115. P. Jeon, M. Choi, J. Oh, and M. Lee Dexamethasone-conjugated polyamidoamine dendrimer for delivery of the heme oxygenase-1 gene into the ischemic brain Macromol. Biosci. 15 2015 1021 1028
116. F. Jin, Q. Wu, Y.F. Lu, Q.H. Gong, and J.S. Shi Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats Eur. J. Pharmacol. 600 2008 78 82
117. H. Jin, W.Q. Chen, X.W. Tang, L.Y. Chiang, C.Y. Yang, J.V. Schloss, and J.Y. Wu Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agents J. Neurosci. Res. 62 2000 600 607
118. A.V. Kabanov, and H.E. Gendelman Nanomedicine in the diagnosis and therapy of neurodegenerative disorders Prog. Polym. Sci. 32 2007 1054 1082
119. I.J. Kade, and J.B. Rocha Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats Neurochem. Res. 38 2013 761 771
120. V. Kakkar, and I.P. Kaur Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain Food Chem. Toxicol. 49 2011 2906 2913
121. V. Kakkar, A.K. Mishra, K. Chuttani, K. Chopra, and I.P. Kaur Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements Rejuvenat. Res. 14 2011 597 604
122. V. Kakkar, S.K. Muppu, K. Chopra, and I.P. Kaur Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats Eur. J. Pharm. Biopharm. 85 2013 339 345
123. V. Kakkar, S. Singh, D. Singla, and I.P. Kaur Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin Mol. Nutr. Food Res. 55 2011 495 503
124. A. Kalani, P.K. Kamat, P. Chaturvedi, S.C. Tyagi, and N. Tyagi Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia Life Sci. 107 2014 1 7
125. B. Kang, M.A. Mackey, and M.A. El-Sayed Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis J. Am. Chem. Soc. 132 2010 1517 1519
126. K.S. Kang, Y. Wen, N. Yamabe, M. Fukui, S.C. Bishop, and B.T. Zhu Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies PLoS One 5 2010 e11951
127. O. Kantarci, and D. Wingerchuk Epidemiology and natural history of multiple sclerosis: new insights Curr. Opin. Neurol. 19 2006 248 254
128. A.S. Karakoti, N.A. Monteiro-Riviere, R. Aggarwal, J.P. Davis, R.J. Narayan, W.T. Self, J. McGinnis, and S. Seal Nanoceria as antioxidant: synthesis and biomedical applications JOM (1989) 60 2008 33 37
129. A.S. Karakoti, S. Singh, A. Kumar, M. Malinska, S.V. Kuchibhatla, K. Wozniak, W.T. Self, and S. Seal PEGylated nanoceria as radical scavenger with tunable redox chemistry J. Am. Chem. Soc. 131 2009 14144 14145
130. C.B. Kim, Y.Y. Choi, W.K. Song, and K.B. Song Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor J. Biomed. Opt. 19 2014 051205
131. D. Kim, and L.H. Tsai Bridging physiology and pathology in AD Cell 137 2009 997 1000
132. D.S. Kim, J.Y. Kim, and Y. Han Curcuminoids in neurodegenerative diseases Recent Pat. CNS Drug Discov. 7 2012 184 204
133. H.S. Kim, M.J. Quon, and J.A. Kim New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate Redox Biol. 2 2014 187 195
134. Y.A. Kim, S.Y. Lim, S.H. Rhee, K.Y. Park, C.H. Kim, B.T. Choi, S.J. Lee, Y.M. Park, and Y.H. Choi Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells Int. J. Mol. Med. 17 2006 1069 1075
135. B. Klajnert, T. Wasiak, M. Ionov, M. Fernandez-Villamarin, A. Sousa-Herves, J. Correa, R. Riguera, and E. Fernandez-Megia Dendrimers reduce toxicity of Abeta 1-28 peptide during aggregation and accelerate fibril formation Nanomedicine 8 2012 1372 1378
136. N.L. Klyachko, D.S. Manickam, A.M. Brynskikh, S.V. Uglanova, S. Li, S.M. Higginbotham, T.K. Bronich, E.V. Batrakova, and A.V. Kabanov Cross-linked antioxidant nanozymes for improved delivery to CNS Nanomedicine 8 2012 119 129
137. G.W. Konat, and R.C. Wiggins Effect of reactive oxygen species on myelin membrane proteins J. Neurochem. 45 1985 1113 1118
138. M.S. Korani, Y. Farbood, A. Sarkaki, H. Fathi Moghaddam, and M. Taghi Mansouri Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats Eur. J. Pharmacol. 733 2014 62 67
139. C. Korsvik, S. Patil, S. Seal, and W.T. Self Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles Chem. Commun. (Camb.) 2007 1056 1058
140. P. Kovacic, and R. Somanathan Biomechanisms of nanoparticles (toxicants, antioxidants and therapeutics): electron transfer and reactive oxygen species J. Nanosci. Nanotechnol. 10 2010 7919 7930
141. J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, K. Cychutek, C. Koch-Brandt, and R. Alyautdin Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J. Drug Target 10 2002 317 325
142. R. Krogh, R.A. Yunes, and A.D. Andricopulo Structure-activity relationships for the analgesic activity of gallic acid derivatives Farmaco 55 2000 730 735
143. A. Kumar, N. Sehgal, P. Kumar, S.S. Padi, and P.S. Naidu Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats Phytother. Res. 22 2008 1563 1569
144. P. Kumar, H. Kalonia, and A. Kumar Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats J. Asian Nat. Prod. Res. 11 2009 439 450
145. M.A. Lauzon, A. Daviau, B. Marcos, and N. Faucheux Nanoparticle-mediated growth factor delivery systems: a new way to treat Alzheimer's disease J. Control Release 206 2015 187 205
146. H. Lee, J.H. Bae, and S.R. Lee Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils J. Neurosci. Res. 77 2004 892 900
147. J.C. Lee, J. Kim, J.K. Park, G.H. Chung, and Y.S. Jang The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis Exp. Cell Res. 291 2003 386 397
148. T.S. Levchenko, R. Rammohan, A.N. Lukyanov, K.R. Whiteman, and V.P. Torchilin Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating Int. J. Pharm. 240 2002 95 102
149. Y. Levites, T. Amit, M.B. Youdim, and S. Mandel Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action J. Biol. Chem. 277 2002 30574 30580
150. L. Li, C. Wang, K. Liu, Y. Wang, and Y. Lin Hexagonal cobalt oxyhydroxide-carbon dots hybridized surface: high sensitive fluorescence turn-on probe for monitoring of ascorbic acid in rat brain following brain ischemia Anal. Chem. 87 2015 3404 3411
151. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 2008 496 504
152. Q. Liang, A.D. Smith, S. Pan, V.A. Tyurin, V.E. Kagan, T.G. Hastings, and N.F. Schor Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease Biochem. Pharmacol. 70 2005 1371 1381
153. E.A. Liberman, V.P. Topaly, L.M. Tsofina, A.A. Iasaitis, and V.P. Skulachev Ion transport and electrical potential of mitochondrial membranes Biokhimiia 34 1969 1083 1087
154. A.M. Lin, B.Y. Chyi, S.D. Wang, H.H. Yu, P.P. Kanakamma, T.Y. Luh, C.K. Chou, and L.T. Ho Carboxyfullerene prevents iron-induced oxidative stress in rat brain J. Neurochem. 72 1999 1634 1640
155. C.F. Lin, K.H. Yu, C.P. Jheng, R. Chung, and C.I. Lee Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress Pathogens 2 2013 506 519
156. M. Lindgren, M. Hallbrink, A. Prochiantz, and U. Langel Cell-penetrating peptides Trends Pharmacol. Sci. 21 2000 99 103
157. D. Liu, A. Mori, and L. Huang Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes Biochim. Biophys. Acta 1104 1992 95 101
158. J. Liu, H. Yu, and X. Ning Effect of quercetin on chronic enhancement of spatial learning and memory of mice Sci. China C Life Sci. 49 2006 583 590
159. Z. Liu, L. Zhang, Q. He, X. Liu, O. Chukwunweike Ikechukwu, L. Tong, L. Guo, H. Yang, Q. Zhang, H. Zhao, and X. Gu Effect of baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats Int. J. Pharm. 489 2015 131 138
160. P.R. Lockman, R.J. Mumper, M.A. Khan, and D.D. Allen Nanoparticle technology for drug delivery across the blood-brain barrier Drug Dev. Ind. Pharm. 28 2002 1 13
161. P.R. Lockman, M.O. Oyewumi, J.M. Koziara, K.E. Roder, R.J. Mumper, and D.D. Allen Brain uptake of thiamine-coated nanoparticles J. Control Release 93 2003 271 282
162. W. Lu, Y.Z. Tan, K.L. Hu, and X.G. Jiang Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier Int. J. Pharm. 295 2005 247 260
163. X. Lu, H. Xu, B. Sun, Z. Zhu, D. Zheng, and X. Li Enhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture Mol. Pharm. 10 2013 2045 2053
164. Z. Lu, G. Nie, P.S. Belton, H. Tang, and B. Zhao Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives Neurochem. Int. 48 2006 263 274
165. S. Lung, F.R. Cassee, I. Gosens, and A. Campbell Brain suppression of AP-1 by inhaled diesel exhaust and reversal by cerium oxide nanoparticles Inhal. Toxicol. 26 2014 636 641
166. Q.L. Ma, F. Yang, E.R. Rosario, O.J. Ubeda, W. Beech, D.J. Gant, P.P. Chen, B. Hudspeth, C. Chen, Y. Zhao, H.V. Vinters, S.A. Frautschy, and G.M. Cole Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin J. Neurosci. 29 2009 9078 9089
167. X. Ma, Z. Sun, Y. Liu, Y. Jia, B. Zhang, and J. Zhang Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia Neural Regen. Res. 8 2013 2050 2059
168. D.G. MacGregor, M.V. Avshalumov, and M.E. Rice Brain edema induced by in vitro ischemia: causal factors and neuroprotection J. Neurochem. 85 2003 1402 1411
169. S.J. Madsen, S.K. Baek, A.R. Makkouk, T. Krasieva, and H. Hirschberg Macrophages as cell-based delivery systems for nanoshells in photothermal therapy Ann. Biomed. Eng. 40 2012 507 515
170. E.G. Makarova, R.Y. Gordon, and I.Y. Podolski Fullerene C60 prevents neurotoxicity induced by intrahippocampal microinjection of amyloid-beta peptide J. Nanosci. Nanotechnol. 12 2012 119 126
171. C. Mancuso, and E. Barone Curcumin in clinical practice: myth or reality? Trends Pharmacol. Sci. 30 2009 333 334
172. M.T. Mansouri, B. Naghizadeh, B. Ghorbanzadeh, Y. Farbood, A. Sarkaki, and K. Bavarsad Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats Pharmacol. Biochem. Behav. 111 2013 90 96
173. R. Martin, C. Menchon, N. Apostolova, V.M. Victor, M. Alvaro, J.R. Herance, and H. Garcia Nano-jewels in biology. Gold and platinum on diamond nanoparticles as antioxidant systems against cellular oxidative stress ACS Nano 4 2010 6957 6965
174. A. Marushima, K. Suzuki, Y. Nagasaki, T. Yoshitomi, K. Toh, H. Tsurushima, A. Hirayama, and A. Matsumura Newly synthesized radical-containing nanoparticles enhance neuroprotection after cerebral ischemia-reperfusion injury Neurosurgery 68 1418-1425 2011 (discussion 1425-1416)
175. A. Mathew, T. Fukuda, Y. Nagaoka, T. Hasumura, H. Morimoto, Y. Yoshida, T. Maekawa, K. Venugopal, and D.S. Kumar Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease PLoS One 7 2012 e32616
176. J.M. McCarthy, D. Appelhans, J. Tatzelt, and M.S. Rogers Nanomedicine for prion disease treatment: new insights into the role of dendrimers Prion 7 2013 198 202
177. D. Metodiewa, and C. Koska Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview Neurotox. Res. 1 2000 197 233
178. L. Migliore, C. Uboldi, S. Di Bucchianico, and F. Coppede Nanomaterials and neurodegeneration Environ. Mol. Mutagen 56 2015 149 170
179. T. Minagawa, K. Sakanaka, S. Inaba, Y. Sai, I. Tamai, T. Suwa, and A. Tsuji Blood-brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin I2 analogue J. Pharm. Pharmacol. 48 1996 1016 1022
180. S. Misra, V. Tiwari, A. Kuhad, and K. Chopra Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats Eur. J. Pharmacol. 659 2011 177 186
181. G. Modi, V. Pillay, and Y.E. Choonara Advances in the treatment of neurodegenerative disorders employing nanotechnology Ann. N. Y. Acad. Sci. 1184 2010 154 172
182. G. Modi, V. Pillay, Y.E. Choonara, V.M. Ndesendo, L.C. du Toit, and D. Naidoo Nanotechnological applications for the treatment of neurodegenerative disorders Prog. Neurobiol. 88 2009 272 285
183. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478
184. V.J. Mohanraj, and Y. Chen Nanoparticles - a review Trop. J. Pharm. Res. 5 2006 561 573
185. A. Monroy, G.J. Lithgow, and S. Alavez Curcumin and neurodegenerative diseases Biofactors 39 2013 122 132
186. X. Montet, M. Funovics, K. Montet-Abou, R. Weissleder, and L. Josephson Multivalent effects of RGD peptides obtained by nanoparticle display J. Med. Chem. 49 2006 6087 6093
187. N. Morozova, K. Khrapko, J. Panee, W. Liu, J.W. Harney, and M.J. Berry Glutathione depletion in hippocampal cells increases levels of H and L ferritin and glutathione S-transferase mRNAs Genes Cells 12 2007 561 567
188. S. Mourtas, A.N. Lazar, E. Markoutsa, C. Duyckaerts, and S.G. Antimisiaris Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease Eur. J. Med. Chem. 80 2014 175 183
189. X. Mu, and Z. Zhong Preparation and properties of poly(vinyl alcohol)-stabilized liposomes Int. J. Pharm. 318 2006 55 61
190. B. Mukherjee Nanosize drug delivery system Curr. Pharm. Biotechnol. 14 2013 1221
191. P.J. Mulholland, D.R. Ferry, D. Anderson, S.A. Hussain, A.M. Young, J.E. Cook, E. Hodgkin, L.W. Seymour, and D.J. Kerr Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin Ann. Oncol. 12 2001 245 248
192. V. Muronetz, R. Asryants, P. Semenyuk, E. Schmalhausen, and L. Saso Hydrophobic plant antioxidants. Preparation of nanoparticles and their application for prevention of neurodegenerative diseases. Review and experimental data Curr. Top. Med. Chem. 14 2014 2520 2528
193. M.P. Murphy, and R.A. Smith Targeting antioxidants to mitochondria by conjugation to lipophilic cations Annu. Rev. Pharmacol. Toxicol. 47 2007 629 656
194. H. Nagata, S. Takekoshi, T. Takagi, T. Honma, and K. Watanabe Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase Tokai J. Exp. Clin. Med. 24 1999 1 11
195. K. Nagpal, S.K. Singh, and D. Mishra Influence of the formulation on the maximum tolerated doses of brain targeted nanoparticles of gallic acid by oral administration in Wistar rats J. Pharm. Pharmacol. 65 2013 1757 1764
196. K. Nagpal, S.K. Singh, and D.N. Mishra Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity Drug Deliv. 19 2012 378 391
197. K. Nagpal, S.K. Singh, and D.N. Mishra Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia Drug Deliv. 20 2013 112 119
198. K.B. Narayanan, and H.H. Park Pleiotropic functions of antioxidant nanoparticles for longevity and medicine Adv. Colloid Interface Sci. 201-202 2013 30 42
199. C.M. Nday, E. Halevas, G.E. Jackson, and A. Salifoglou Quercetin encapsulation in modified silica nanoparticles: potential use against Cu(II)-induced oxidative stress in neurodegeneration J. Inorg. Biochem. 145 2015 51 64
200. A. Nel, T. Xia, L. Madler, and N. Li Toxic potential of materials at the nanolevel Science 311 2006 622 627
201. Z. Nie, K.J. Liu, C.J. Zhong, L.F. Wang, Y. Yang, Q. Tian, and Y. Liu Enhanced radical scavenging activity by antioxidant-functionalized gold nanoparticles: a novel inspiration for development of new artificial antioxidants Free Radic. Biol. Med. 43 2007 1243 1254
202. A. Nowacek, L.M. Kosloski, and H.E. Gendelman Neurodegenerative disorders and nanoformulated drug development Nanomed. (Lond.) 4 2009 541 555
203. G. Oberdorster, E. Oberdorster, and J. Oberdorster Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ. Health Perspect. 113 2005 823 839
204. N. Omori, K. Maruyama, G. Jin, F. Li, S.J. Wang, Y. Hamakawa, K. Sato, I. Nagano, M. Shoji, and K. Abe Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin Neurol. Res. 25 2003 275 279
205. G. Pagona, and N. Tagmatarchis Carbon nanotubes: materials for medicinal chemistry and biotechnological applications Curr. Med. Chem. 13 2006 1789 1798
206. M. Paranjpe, J.H. Finke, C. Richter, T. Gothsch, A. Kwade, S. Buttgenbach, and C.C. Muller-Goymann Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application Int. J. Pharm. 476 2014 41 49
207. C. Pardeshi, P. Rajput, V. Belgamwar, A. Tekade, G. Patil, K. Chaudhary, and A. Sonje Solid lipid based nanocarriers: an overview Acta Pharm. 62 2012 433 472
208. W.M. Pardridge Drug targeting to the brain Pharm. Res. 24 2007 1733 1744
209. W.M. Pardridge, J. Eisenberg, and J. Yang Human blood-brain barrier transferrin receptor Metabolism 36 1987 892 895
210. V.K. Parihar, K.R. Prabhakar, V.P. Veerapur, M.S. Kumar, Y.R. Reddy, R. Joshi, M.K. Unnikrishnan, and C.M. Rao Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice Mutat. Res. 611 2006 9 16
211. N. Pellegrini, M. Serafini, B. Colombi, D. Del Rio, S. Salvatore, M. Bianchi, and F. Brighenti Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays J. Nutr. 133 2003 2812 2819
212. A.E. Pelling, S. Sehati, E.B. Gralla, J.S. Valentine, and J.K. Gimzewski Local nanomechanical motion of the cell wall of Saccharomyces cerevisiae Science 305 2004 1147 1150
213. K.C. Petkar, S.S. Chavhan, S. Agatonovik-Kustrin, and K.K. Sawant Nanostructured materials in drug and gene delivery: a review of the state of the art Crit. Rev. Ther. Drug Carr. Syst. 28 2011 101 164
214. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
215. D.J. Piñero, and J.R. Connor Iron in the brain: an important contributor in normal and diseased states Neuroscientist 6 2000 435
216. M.C. Polidori, H.R. Griffiths, E. Mariani, and P. Mecocci Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease Amino Acids 32 2007 553 559
217. T. Pralhad, and K. Rajendrakumar Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis J. Pharm. Biomed. Anal. 34 2004 333 339
218. J. Prasad, I. Baitharu, A.K. Sharma, R. Dutta, D. Prasad, and S.B. Singh Quercetin reverses hypobaric hypoxia-induced hippocampal neurodegeneration and improves memory function in the rat High. Alt. Med. Biol. 14 2013 383 394
219. N.R. Prasad, T. Mahesh, V.P. Menon, R.K. Jeevanram, and K.V. Pugalendi Photoprotective effect of sesamol on UVB-radiation induced oxidative stress in human blood lymphocytes in vitro Environ. Toxicol. Pharmacol. 20 2005 1 5
220. F. Pu, K. Mishima, K. Irie, K. Motohashi, Y. Tanaka, K. Orito, T. Egawa, Y. Kitamura, N. Egashira, K. Iwasaki, and M. Fujiwara Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats J. Pharmacol. Sci. 104 2007 329 334
221. L. Rajendran, H.J. Knolker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
222. R. Rak, D.L. Chao, R.M. Pluta, J.B. Mitchell, E.H. Oldfield, and J.C. Watson Neuroprotection by the stable nitroxide tempol during reperfusion in a rat model of transient focal ischemia J. Neurosurg. 92 2000 646 651
223. P. Ramalingam, and Y.T. Ko Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations Pharm. Res. 32 2015 389 402
224. M.K. Reddy, and V. Labhasetwar Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury FASEB J. 23 2009 1384 1395
225. W.M. Renno, M. Al-Maghrebi, A. Alshammari, and P. George (-)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury Neurochem. Int. 62 2013 221 231
226. J.M. Ringman, S.A. Frautschy, G.M. Cole, D.L. Masterman, and J.L. Cummings A potential role of the curry spice curcumin in Alzheimer's disease Curr. Alzheimer Res. 2 2005 131 136
227. R.J. Rodriguez, C.L. Miranda, J.F. Stevens, M.L. Deinzer, and D.R. Buhler Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes Food Chem. Toxicol. 39 2001 437 445
228. E.G. Rosenbaugh, J.W. Roat, L. Gao, R.F. Yang, D.S. Manickam, J.X. Yin, H.D. Schultz, T.K. Bronich, E.V. Batrakova, A.V. Kabanov, I.H. Zucker, and M.C. Zimmerman The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase Biomaterials 31 2010 5218 5226
229. A.K. Sachdeva, S. Misra, I. Pal Kaur, and K. Chopra Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence Eur. J. Pharmacol. 747 2015 132 140
230. N. Sakai, R. Mizuno, N. Ono, H. Kato, and T. Ohhashi High oxygen tension constricts epineurial arterioles of the rat sciatic nerve via reactive oxygen species Am. J. Physiol. Heart Circ. Physiol. 293 2007 H1498 H1507
231. N.M. Sakhrani, and H. Padh Organelle targeting: third level of drug targeting Drug Des. Develop. Ther. 7 2013 585 599
232. S.S. Salunkhe, N.M. Bhatia, and M.S. Bhatia Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain Drug Deliv. 2014 1 11
233. E.L. Samuel, D.C. Marcano, V. Berka, B.R. Bitner, G. Wu, A. Potter, R.H. Fabian, R.G. Pautler, T.A. Kent, A.L. Tsai, and J.M. Tour Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters Proc. Natl. Acad. Sci. U. S. A. 112 2015 2343 2348
234. A. Samuni, C.M. Krishna, J.B. Mitchell, C.R. Collins, and A. Russo Superoxide reaction with nitroxides Free Radic. Res. Commun. 9 1990 241 249
235. R. Sandhir, N. Mahajan, A. Mehrotra, A. Aggarwal, and A. Sunkaria 4-hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington's disease Synapse 69 2015 128 138
236. R. Sandhir, and A. Mehrotra Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease Biochim. Biophys. Acta 1832 2013 421 430
237. R. Sandhir, A. Yadav, A. Mehrotra, A. Sunkaria, A. Singh, and S. Sharma Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease Neuromol. Med. 16 2014 106 118
238. V. Sanna, N. Pala, G. Dessi, P. Manconi, A. Mariani, S. Dedola, M. Rassu, C. Crosio, C. Iaccarino, and M. Sechi Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities Int. J. Nanomed. 9 2014 4935 4951
239. H. Schirmer, T.C. Pereira, E.P. Rico, D.B. Rosemberg, C.D. Bonan, M.R. Bogo, and A.A. Souto Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1alpha and NAMPT gene expression profiles in wild-type adult zebrafish liver Mol. Biol. Rep. 39 2012 3281 3289
240. A. Schrag, N.P. Quinn, and Y. Ben-Shlomo Heterogeneity of Parkinson's disease J. Neurol. Neurosurg. Psychiatry 77 2006 275 276
241. A.M. Schrand, M.F. Rahman, S.M. Hussain, J.J. Schlager, D.A. Smith, and A.F. Syed Metal-based nanoparticles and their toxicity assessment Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 2010 544 568
242. U. Schroder, and B.A. Sabel Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections Brain Res. 710 1996 121 124
243. D. Schubert, R. Dargusch, J. Raitano, and S.W. Chan Cerium and yttrium oxide nanoparticles are neuroprotective Biochem. Biophys. Res. Commun. 342 2006 86 91
244. R.M. Shah, F. Malherbe, D. Eldridge, E.A. Palombo, and I.H. Harding Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique J. Colloid Interface Sci. 428 2014 286 294
245. S. Shahrzad, K. Aoyagi, A. Winter, A. Koyama, and I. Bitsch Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans J. Nutr. 131 2001 1207 1210
246. A.M. Sharifi, S. Baniasadi, M. Jorjani, F. Rahimi, and M. Bakhshayesh Investigation of acute lead poisoning on apoptosis in rat hippocampus in vivo Neurosci. Lett. 329 2002 45 48
247. D.R. Sharma, W.Y. Wani, A. Sunkaria, R.J. Kandimalla, D. Verma, S.S. Cameotra, and K.D. Gill Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats Neurotox. Res. 23 2013 336 357
248. S. Sharma, and I.P. Kaur Development and evaluation of sesamol as an antiaging agent Int. J. Dermatol. 45 2006 200 208
249. E. Sharpe, D. Andreescu, and S. Andreescu Artificial nanoparticle antioxidants Oxidat. Stress Diagn. Prev. Ther. 8 2011 235 253
250. K. Shen, X. Feng, R. Su, H. Xie, L. Zhou, and S. Zheng Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation PLoS One 10 2015 e0126278
251. F. Simao, A. Matte, A.S. Pagnussat, C.A. Netto, and C.G. Salbego Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways Eur. J. Neurosci. 36 2012 2899 2905
252. A. Singh, P.S. Naidu, and S.K. Kulkarni Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid Free Radic. Res. 37 2003 1245 1252
253. B. Singh, S. Beg, S. Lohan, and R. Kapil Crossing blood-brain barriers using drug delivery: a successful venture using lipidic nanostructured systems Pharm. Rev. 2013 41 47
254. D. Singh, H. Kapahi, M. Rashid, A. Prakash, A.B. Majeed, and N. Mishra Recent prospective of surface engineered nanoparticles in the management of Neurodegenerative disorders Artif. Cells Nanomed Biotechnol. 2015 1 12
255. A. Singhal, V.B. Morris, V. Labhasetwar, and A. Ghorpade Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress Cell Death Dis. 4 2013 e903
256. A. Smith, B. Giunta, P.C. Bickford, M. Fountain, J. Tan, and R.D. Shytle Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease Int. J. Pharm. 389 2010 207 212
257. N.D. Sonawane, F.C. Szoka Jr., and A.S. Verkman Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes J. Biol. Chem. 278 2003 44826 44831
258. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control Release 70 2001 1 20
259. E.B. Souto, P. Severino, R. Basso, and M.H. Santana Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers Methods Mol. Biol. 1028 2013 37 46
260. C. Spuch, O. Saida, and C. Navarro Advances in the treatment of neurodegenerative disorders employing nanoparticles Recent Pat. Drug Deliv. Formul. 6 2012 2 18
261. B. Sriramoju, R.K. Kanwar, and J.R. Kanwar Nanomedicine based nanoparticles for neurological disorders Curr. Med. Chem. 21 2014 4154 4168
262. S. Stolnik, C.R. Heald, J. Neal, M.C. Garnett, S.S. Davis, L. Illum, S.C. Purkis, R.J. Barlow, and P.R. Gellert Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance J. Drug Target 9 2001 361 378
263. Y. Sugiyama, S. Kawakishi, and T. Osawa Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin Biochem. Pharmacol. 52 1996 519 525
264. J. Suh, K.L. Choy, S.K. Lai, J.S. Suk, B.C. Tang, S. Prabhu, and J. Hanes PEGylation of nanoparticles improves their cytoplasmic transport Int. J. Nanomed. 2 2007 735 741
265. W.H. Suh, K.S. Suslick, G.D. Stucky, and Y.H. Suh Nanotechnology, nanotoxicology, and neuroscience Prog. Neurobiol. 87 2009 133 170
266. J. Sun, Y.Z. Li, Y.H. Ding, J. Wang, J. Geng, H. Yang, J. Ren, J.Y. Tang, and J. Gao Neuroprotective effects of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral ischemia/reperfusion injury in vivo Brain Res. 1589 2014 126 139
267. Z.K. Sun, X.R. Ma, Y.J. Jia, Y.R. Liu, J.W. Zhang, and B.A. Zhang Effects of resveratrol on apoptosis in a rat model of vascular dementia Exp. Ther. Med. 7 2014 843 848
268. G. Testa, P. Gamba, U. Badilli, S. Gargiulo, M. Maina, T. Guina, S. Calfapietra, F. Biasi, R. Cavalli, G. Poli, and G. Leonarduzzi Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols PLoS One 9 2014 e96795
269. S.K. Tiwari, S. Agarwal, B. Seth, A. Yadav, S. Nair, P. Bhatnagar, M. Karmakar, M. Kumari, L.K. Chauhan, D.K. Patel, V. Srivastava, D. Singh, S.K. Gupta, A. Tripathi, R.K. Chaturvedi, and K.C. Gupta Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/beta-catenin pathway ACS Nano 8 2014 76 103
270. V. Tiwari, A. Kuhad, and K. Chopra Epigallocatechin-3-gallate ameliorates alcohol-induced cognitive dysfunctions and apoptotic neurodegeneration in the developing rat brain Int. J. Neuropsychopharmacol. 13 2010 1053 1066
271. S. Tota, H. Awasthi, P.K. Kamat, C. Nath, and K. Hanif Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice Behav. Brain Res. 209 2010 73 79
272. M.C. Tsai, Y.H. Chen, and L.Y. Chiang Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro J. Pharm. Pharmacol. 49 1997 438 445
273. M. Uchida, S. Nakajin, S. Toyoshima, and M. Shinoda Antioxidative effect of sesamol and related compounds on lipid peroxidation Biol. Pharm. Bull. 19 1996 623 626
274. V. Valcour, and R. Paul HIV infection and dementia in older adults Clin. Infect. Dis. 42 2006 1449 1454
275. C. Vauthier, C. Dubernet, E. Fattal, H. Pinto-Alphandary, and P. Couvreur Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications Adv. Drug Deliv. Rev. 55 2003 519 548
276. S.V. Vinogradov, E.V. Batrakova, and A.V. Kabanov Nanogels for oligonucleotide delivery to the brain Bioconjug. Chem. 15 2004 50 60
277. V. Vorobyov, V. Kaptsov, R. Gordon, E. Makarova, I. Podolski, and F. Sengpiel Neuroprotective effects of hydrated fullerene c60: cortical and hippocampal EEG interplay in an amyloid-infused rat model of Alzheimer's disease J. Alzheim. Dis. 45 2015 217 233
278. J.M. Walker, D. Klakotskaia, D. Ajit, G.A. Weisman, W.G. Wood, G.Y. Sun, P. Serfozo, A. Simonyi, and T.R. Schachtman Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model J. Alzheim. Dis. 44 2015 561 572
279. G. Warren, E. Makarov, Y. Lu, T. Senanayake, K. Rivera, S. Gorantla, L.Y. Poluektova, and S.V. Vinogradov Amphiphilic cationic nanogels as brain-targeted carriers for activated nucleoside reverse transcriptase inhibitors J. Neuroimmune Pharmacol. 10 2015 88 101
280. G. Watal, A. Watal, P.K. Rai, D.K. Rai, G. Sharma, and B. Sharma Biomedical applications of nano-antioxidant Methods Mol. Biol. 1028 2013 147 151
281. V. Weissig, and D. Guzman-Villanueva Nanopharmaceuticals (part 2): products in the pipeline Int. J. Nanomed. 10 2015 1245 1257
282. J. Weng, and J. Ren Luminescent quantum dots: a very attractive and promising tool in biomedicine Curr. Med. Chem. 13 2006 897 909
283. E. Wenzel, and V. Somoza Metabolism and bioavailability of trans-resveratrol Mol. Nutr. Food Res. 49 2005 472 481
284. A. Wicki, R. Ritschard, U. Loesch, S. Deuster, C. Rochlitz, and C. Mamot Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial Int. J. Pharm. 484 2015 8 15
285. C.S. Wilcox, and A. Pearlman Chemistry and antihypertensive effects of tempol and other nitroxides Pharmacol. Rev. 60 2008 418 469
286. P. Windrum, T.C. Morris, M.B. Drake, D. Niederwieser, and T. Ruutu Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres Bone Marrow Transpl. 36 2005 601 603
287. T.T. Win-Shwe, and H. Fujimaki Nanoparticles and neurotoxicity Int. J. Mol. Sci. 12 2011 6267 6280
288. J. Wu, J. Sun, and Y. Xue Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells Toxicol. Lett. 199 2010 269 276
289. Y. Xue, J. Wu, and J. Sun Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro Toxicol. Lett. 214 2012 91 98
290. C.S. Yah, G.S. Simate, and S.E. Iyuke Nanoparticles toxicity and their routes of exposures Pak. J. Pharm. Sci. 25 2012 477 491
291. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P. Chen, R. Kayed, C.G. Glabe, S.A. Frautschy, and G.M. Cole Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 280 2005 5892 5901
292. J.Y. Yang, and D.G. Nocera Catalase and epoxidation activity of manganese salen complexes bearing two xanthene scaffolds J. Am. Chem. Soc. 129 2007 8192 8198
293. Y.X. Yang, Z.M. Song, B. Cheng, K. Xiang, X.X. Chen, J.H. Liu, A. Cao, Y. Wang, Y. Liu, and H. Wang Evaluation of the toxicity of food additive silica nanoparticles on gastrointestinal cells J. Appl. Toxicol. 34 2014 424 435
294. Y. Yao, D.D. Han, T. Zhang, and Z. Yang Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons Phytother. Res. 24 2010 136 140
295. K.A. Youdim, M.S. Dobbie, G. Kuhnle, A.R. Proteggente, N.J. Abbott, and C. Rice-Evans Interaction between flavonoids and the blood-brain barrier: in vitro studies J. Neurochem. 85 2003 180 192
296. Z.P. Yuan, L.J. Chen, Y.Q. Wei, L.Y. Fan, M.H. Tang, and G.L. Yang Nanoliposomal quercetin inhibits formation of malignant ascites of hepatocellular carcinoma Ai Zheng 25 2006 941 945
297. X. Yun, V.D. Maximov, J. Yu, H. Zhu, A.A. Vertegel, and M.S. Kindy Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury J. Cereb. Blood Flow. Metab. 33 2013 583 592
298. F. Zhang, J.S. Shi, H. Zhou, B. Wilson, J.S. Hong, and H.M. Gao Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions Mol. Pharmacol. 78 2010 466 477
299. J. Zhang, X. Zhou, Q. Yu, L. Yang, D. Sun, Y. Zhou, and J. Liu Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-beta aggregation and cytotoxicity ACS Appl. Mater Interfaces 6 2014 8475 8487
300. J.S. Zhang, F. Liu, and L. Huang Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity Adv. Drug Deliv. Rev. 57 2005 689 698
301. T. Zhang, J. Zhang, P. Derreumaux, and Y. Mu Molecular mechanism of the inhibition of EGCG on the Alzheimer Abeta(1-42) dimer J. Phys. Chem. B 117 2013 3993 4002
302. X.M. Zhou, M.L. Zhou, X.S. Zhang, Z. Zhuang, T. Li, J.X. Shi, and X. Zhang Resveratrol prevents neuronal apoptosis in an early brain injury model J. Surg. Res. 189 2014 159 165